Johnson & Johnson stock slips on fresh talc verdict — what JNJ investors watch next
Johnson & Johnson shares fell 0.4% to $243.50 Friday after a Pennsylvania jury awarded $250,000 in a talc cancer case against the company. The verdict included $200,000 in punitive damages. Investors are watching for more trial outcomes and J&J’s April 14 results call. The company faces over 67,000 talc-related lawsuits.